Page last updated: 2024-11-05

troglitazone and Myositis, Multiple

troglitazone has been researched along with Myositis, Multiple in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujibayashi, K1
Nagasaka, S1
Itabashi, N1
Kawakami, A1
Nakamura, T1
Kusaka, I1
Ishikawa, S1
Saito, T1

Other Studies

1 other study available for troglitazone and Myositis, Multiple

ArticleYear
Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.
    Diabetes care, 1999, Volume: 22, Issue:12

    Topics: Aged; C-Peptide; Chromans; Diabetes Mellitus; Female; Glucocorticoids; Humans; Hypoglycemic Agents;

1999